journal article·2026-12-31Open access

Protective effect of Salvia Miltiorrhiza Injection on myocardial injury in rats with haemorrhagic shock resuscitated by HBOC-CHP01

Shasha Hao, Xintong Xie, Shen Li, Honghui Zhang, Hong Wang, Chengmin Yang, Wentao Zhou, Jiaxin Liu

Abstract

This study investigated whether Salvia Miltiorrhiza Injection (SMI) could mitigate acute myocardial injury following resuscitation from severe haemorrhagic shock with the hemoglobin-based oxygen carrier HBOC-CHP01. Network pharmacology was first used to predict SMI's potential mechanisms. In vivo, a 50% severe haemorrhagic shock model was induced in rats, which were then resuscitated with either HBOC-CHP01 alone (n=12) or HBOC-CHP01 plus SMI (8.0 ml/kg, n=12). Subgroups were assessed for 72-hour survival, blood parameters, and myocardial tissue injury at 24 hours post-resuscitation. Network pharmacology identified 189 potential targets, with AKT1, CASP3, and HIF-1α among the core candidates. In vivo, while 72-hour survival was unchanged, SMI significantly reduced plasma cardiac injury markers (AST, LDH, CK, cTnI) at 24 hours post-resuscitation compared to HBOC-CHP01 alone. Histological analysis revealed markedly reduced myocardial inflammation and apoptosis in the SMI-treated group. This cardioprotection was associated with significant upregulation of myocardial Nrf2 and HO-1, alongside reduced reactive oxygen species and myeloperoxidase levels. In conclusion, SMI reduces myocardial injury after HBOC-CHP01 resuscitation in haemorrhagic shock rats, primarily by activating the Nrf2/HO-1 antioxidant pathway, suggesting its potential as an adjunctive therapy to improve the safety of hemoglobin-based oxygen carriers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hemoglobin structure and function · Medicinal Plants and Bioactive Compounds · Hydrogen's biological and therapeutic effects

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College

Funding

Chinese Academy of Medical Sciences · Sichuan Provincial Administration of Traditional Chinese Medicine

References (25)

Show source-provided references
1. 10.55460/ovop-v2qc10.55460/ovop-v2qc ↗
2. 10.1053/j.seminhematol.2019.11.00610.1053/j.seminhematol.2019.11.006 ↗
3. 10.3390/medicina5902039610.3390/medicina59020396 ↗
4. 10.1213/ANE.000000000000395710.1213/ANE.0000000000003957 ↗
5. 10.3389/fmed.2021.79456110.3389/fmed.2021.794561 ↗
6. 10.1111/trf.1372610.1111/trf.13726 ↗
7. 10.1111/j.1537-2995.2009.02356.x10.1111/j.1537-2995.2009.02356.x ↗
8. 10.1001/jama.299.19.jrv8000710.1001/jama.299.19.jrv80007 ↗
9. 10.1016/j.tibtech.2014.02.00610.1016/j.tibtech.2014.02.006 ↗
10. 10.1097/SHK.000000000000104410.1097/SHK.0000000000001044 ↗
11. 10.3390/antiox909085710.3390/antiox9090857 ↗
12. 10.7150/thno.5317010.7150/thno.53170 ↗
13. 10.3892/etm.2019.746210.3892/etm.2019.7462 ↗
14. 10.3109/21691401.2012.74499510.3109/21691401.2012.744995 ↗
15. 10.3109/21691401.2014.93445510.3109/21691401.2014.934455 ↗
16. ANIMALS N R C U C F T U O T G F T C A U O L (Committee for the Update of the Guide for the Care and Use of Laboratory Animals). Guide for the care and use of laboratory animals. Washington (DC); 2011.
17. 10.3389/fmedt.2022.104895110.3389/fmedt.2022.1048951 ↗
18. 10.1080/21691401.2024.236744410.1080/21691401.2024.2367444 ↗
19. 10.1155/2020/201803510.1155/2020/2018035 ↗
20. 10.3390/pharmaceutics1509223510.3390/pharmaceutics15092235 ↗
21. 10.1186/s13020-024-00908-y10.1186/s13020-024-00908-y ↗
22. 10.3892/ijmm.2017.333810.3892/ijmm.2017.3338 ↗
23. 10.1007/s11596-017-1801-110.1007/s11596-017-1801-1 ↗
24. 10.1016/j.freeradbiomed.2018.01.02410.1016/j.freeradbiomed.2018.01.024 ↗
25. 10.1586/ecp.09.4110.1586/ecp.09.41 ↗